Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity

Maaike Heslinga; Gilles Lambert; Aurélie Thédrez; John Kastelein; Michael T. Nurmohamed

doi:https://doi.org/10.1093/rheumatology/keab187

Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity

Maaike Heslinga, Gilles Lambert, Aurélie Thédrez, John Kastelein, Michael T. Nurmohamed

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	e292-e293
Journal	Rheumatology (Oxford, England)
Volume	60
Issue number	8
DOIs	https://doi.org/10.1093/rheumatology/keab187
Publication status	Published - 2 Aug 2021

Keywords

Dyslipidemias
Humans
Spondylarthritis
Subtilisins

Access to Document

https://doi.org/10.1093/rheumatology/keab187

Cite this

Heslinga, M., Lambert, G., Thédrez, A., Kastelein, J., & Nurmohamed, M. T. (2021). Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity. Rheumatology (Oxford, England), 60(8), e292-e293. https://doi.org/10.1093/rheumatology/keab187

Heslinga, Maaike ; Lambert, Gilles ; Thédrez, Aurélie et al. / Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity : Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity. In: Rheumatology (Oxford, England). 2021 ; Vol. 60, No. 8. pp. e292-e293.

@article{9570af8a92434241a09a0b35752f026b,

title = "Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity",

keywords = "Dyslipidemias, Humans, Spondylarthritis, Subtilisins",

author = "Maaike Heslinga and Gilles Lambert and Aur{\'e}lie Th{\'e}drez and John Kastelein and Nurmohamed, {Michael T.}",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2021",

month = aug,

day = "2",

doi = "https://doi.org/10.1093/rheumatology/keab187",

language = "English",

volume = "60",

pages = "e292--e293",

journal = "Rheumatology (Oxford, England)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "8",

}

Heslinga, M, Lambert, G, Thédrez, A, Kastelein, J & Nurmohamed, MT 2021, 'Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity', Rheumatology (Oxford, England), vol. 60, no. 8, pp. e292-e293. https://doi.org/10.1093/rheumatology/keab187

Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity. / Heslinga, Maaike; Lambert, Gilles; Thédrez, Aurélie et al.
In: Rheumatology (Oxford, England), Vol. 60, No. 8, 02.08.2021, p. e292-e293.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity

T2 - Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity

AU - Heslinga, Maaike

AU - Lambert, Gilles

AU - Thédrez, Aurélie

AU - Kastelein, John

AU - Nurmohamed, Michael T.

N1 - Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2021/8/2

Y1 - 2021/8/2

KW - Dyslipidemias

KW - Humans

KW - Spondylarthritis

KW - Subtilisins

UR - http://www.scopus.com/inward/record.url?scp=85113713547&partnerID=8YFLogxK

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85113713547&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/33668055

U2 - https://doi.org/10.1093/rheumatology/keab187

DO - https://doi.org/10.1093/rheumatology/keab187

M3 - Comment/Letter to the editor

C2 - 33668055

SN - 1462-0324

VL - 60

SP - e292-e293

JO - Rheumatology (Oxford, England)

JF - Rheumatology (Oxford, England)

IS - 8

ER -

Heslinga M, Lambert G, Thédrez A, Kastelein J , Nurmohamed MT. Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity. Rheumatology (Oxford, England). 2021 Aug 2;60(8):e292-e293. doi: https://doi.org/10.1093/rheumatology/keab187

Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity

Keywords

Access to Document

Other files and links

Cite this